Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
04/03/2026 22:41
March 4 (Reuters) - SEC Filing: MAIA BIOTECHNOLOGY INC - ON MARCH 2, CO ENTERS UNDERWRITING AGREEMENT WITH KONIK CAPITAL PARTNERS ON MARCH 2, 2026 - SEC FILING MAIA BIOTECHNOLOGY INC - TO ISSUE 20,000,000 SHARES OF COMMON STOCK IN PUBLIC OFFERING - SEC FILING Source text: [ID:n0001493152-26-008897] Further company coverage: MAIA.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale